Your browser doesn't support javascript.
loading
A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young, Paul J; Bagshaw, Sean M; Forbes, Andrew; Nichol, Alistair; Wright, Stephen E; Bellomo, Rinaldo; Bailey, Michael J; Beasley, Richard W; Eastwood, Glenn M; Festa, Marino; Gattas, David; van Haren, Frank; Litton, Edward; Mouncey, Paul R; Navarra, Leanlove; Pilcher, David; Mackle, Diane M; McArthur, Colin J; McGuinness, Shay P; Saxena, Manoj K; Webb, Steve; Rowan, Kathryn M.
Afiliación
  • Young PJ; Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand. Paul.Young@ccdhb.org.nz.
  • Bagshaw SM; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
  • Forbes A; Biostatistics Unit, Department of Epidemiology and Preventive Medicine at Monash University, Melbourne, Vic, Australia.
  • Nichol A; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Wright SE; Department of Perioperative and Critical Care, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
  • Bellomo R; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Bailey MJ; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Beasley RW; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Eastwood GM; Intensive Care Unit, Austin Hospital, Melbourne, Vic, Australia.
  • Festa M; Intensive Care Unit, Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Gattas D; Intensive Care Unit, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • van Haren F; Intensive Care Unit, Canberra Hospital, Canberra, ACT, Australia.
  • Litton E; Intensive Care Unit, Fiona Stanley Hospital, Perth, WA, Australia.
  • Mouncey PR; Clinical Trials Unit, Intensive Care National Audit and Research Centre, London, United Kingdom.
  • Navarra L; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Pilcher D; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Mackle DM; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • McArthur CJ; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • McGuinness SP; Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Saxena MK; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Webb S; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Rowan KM; Clinical Trials Unit, Intensive Care National Audit and Research Centre, London, United Kingdom.
Crit Care Resusc ; 20(3): 182-189, 2018 Sep.
Article en En | MEDLINE | ID: mdl-30153780
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Gástrica / Inhibidores de la Bomba de Protones / Antagonistas de los Receptores H2 de la Histamina / Unidades de Cuidados Intensivos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Crit Care Resusc Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Países Bajos
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Gástrica / Inhibidores de la Bomba de Protones / Antagonistas de los Receptores H2 de la Histamina / Unidades de Cuidados Intensivos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Crit Care Resusc Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Países Bajos